Positron POSC

OTC POSC
$1.64 -0.05 (-2.96%)
At close: Nov 13, 2026 · 4:00 PM EST

Positron (POSC) stock price is $1.64, down 2.96% on the day, as of Nov 13, 2026. It has a market cap of $54.28Mn, and is classified in the Diagnostic Equipment industry (Healthcare sector).

Key Stats
Market Cap54.28 Mn
P/E-5.36
FCF (Yr)-4.60 Mn
ROA (Yr)-365.11
EV to EBIT-4.81
Net Income (Yr)-10.60 Mn
Enterprise Value48.07 Mn
Add ratio to table…

About

Positron Corporation is a medical technology company that co-develops, manufactures, and sells PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions. The company combines proprietary PET and PET-CT systems with comprehensive clinical and technical support, flexible financing, and a focus on…

Read more ↓
Sector: Healthcare Sector rationale Positron designs, manufactures, and sells PET and PET-CT imaging systems, which are classified as medical devices. Its revenue is derived from selling these systems and providing associated clinical and technical support to hospitals and outpatient centers. Industries: Diagnostic Equipment Diagnostic Equipment Primary Positron designs, manufactures, and sells PET and PET-CT imaging systems, which are clinical diagnostic equipment used for molecular imaging in cardiology, oncology, and neurology. Revenue is generated from the sale of these systems and associated reagents/services, fitting the description of diagnostic equipment. Healthcare Services Healthcare Services Secondary The company provides clinical over-read support and billing/prior-authorization assistance to healthcare providers, which are outpatient-style healthcare services delivered to support the diagnosis and treatment of patients. Classified using BQ-MICS CIK: 0000844985

Product and Service Breakdown of Revenue (2025)

History
Peer percentiles

How Positron ranks

Ranked against the 252 companies in Medical Devices and Diagnostics58 metrics · as of Nov 14, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −5.36xMedian 26.5x 44th
  • P/FCFNegative free cash flow −15.2xMedian 25.4x 47th
  • P/Operating cash flowNegative operating cash flow −14.4xMedian 20.7x 43rd
  • P/S 124xMedian 2.70x 4th
  • P/BNegative shareholder equity −98.6xMedian 2.48x Not meaningful —
  • P/Tangible bookNegative tangible equity −98.6xMedian 3.10x Not meaningful —
  • EV/EBITDANegative EBITDA −5.65xMedian 18.4x 32nd
  • EV/EBITNegative EBIT −5.59xMedian 29.4x 34th
  • EV/Revenue 128xMedian 3.13x 4th
  • EV/FCFNegative free cash flow −15.6xMedian 28.7x 40th
  • EV/Operating cash flowNegative operating cash flow −14.9xMedian 21.4x 36th
  • PEG (3Y EPS CAGR) —Median 0.98 No data —
Peer group

Peer Comparison

Companies in the Diagnostic Equipment
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 259.44 Bn36.635.4841.37 Bn
2 ABT Abbott Laboratories 187.98 Bn40.053.9031.16 Bn
3 DHR Danaher Corp /De/ 163.91 Bn37.876.4026.48 Bn
4 ISRG Intuitive Surgical Inc 153.75 Bn52.3513.28-
5 MDT Medtronic plc 131.67 Bn15.043.5528.15 Bn
6 SYK Stryker Corp 117.84 Bn32.654.4814.93 Bn
7 BSX Boston Scientific Corp 64.27 Bn18.343.0511.95 Bn
8 POSC Positron Corp 0.05 Bn-5.36124.350.00 Bn